Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
Titel:
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
Auteur:
Broome, Catherine M McDonald, Vickie Miyakawa, Yoshitaka Carpenedo, Monica Kuter, David J Al-Samkari, Hanny Bussel, James B Godar, Marie Ayguasanosa, Jaume De Beuf, Kristof Rodeghiero, Francesco Michel, Marc Newland, Adrian